ArticleInfectious diseases and therapy2024

A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol.

Beatriz Arns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.